Literature DB >> 30888963

Association of IRS1 genetic variants with glucose control and insulin resistance in type 2 diabetic patients from Bosnia and Herzegovina.

Lejla Mahmutovic1, Tamer Bego2, Maria Sterner3, Gabriella Gremsperger3, Emma Ahlqvist3, Zelija Velija Asimi4, Besim Prnjavorac5, Nour Hamad6, Adlija Causevic2, Leif Groop3, Sabina Semiz2,6.   

Abstract

Background Previous studies reported conflicting results regarding association of insulin receptor substrate 1 (IRS1) gene variation with type 2 diabetes (T2D) and insulin resistance (IR) in different ethnic groups. We examined the association of rs7578326, rs2943641, and rs4675095 in the IRS1 gene with T2D and related traits in a population from Bosnia and Herzegovina, which is one of the European countries with the highest T2D prevalence of 12.5%. Methods Our study included 390 T2D patients and 252 control subjects. Biochemical parameters, including fasting glucose (FG), fasting insulin (FI), homeostasis model assessment insulin resistance index (HOMA-IR), and HbA1c were measured in all participants. Genotyping analysis was performed by Mass Array Sequenom iPlex platform. Results Our results demonstrated that rs7578326 and rs4675095 variants were associated with increased FG levels. The rs7578326 was also associated with higher FI, HOMA-IR (B = 0.08, 95% CI [0.01, 0.15], padd = 0.025; B = 0.079, 95% CI [0.006, 0.150], padd = 0.033, respectively) in T2D, and with HbA1c (B = 0.034, 95% CI [0.003, 0.065], pdom = 0.035) in non-drug-treated T2D. In contrast, rs2943641 C allele was associated with lower FG levels in control subjects (B = -0.17, 95% CI [-0.03, -0.002], padd = 0.030) and HbA1c (B = 0.03, 95% CI [0.002, 0.06], pdom = 0.040) in non-drug-treated T2D. Conclusions We report the association between common variants in IRS1 gene with insulin resistance, glucose, and HbA1c levels in Bosnia and Herzegovina's population.

Entities:  

Keywords:  HOMA-IR; HbA1c; IRS1; fasting glucose; insulin resistance; single nucleotide polymorphism

Mesh:

Substances:

Year:  2019        PMID: 30888963     DOI: 10.1515/dmpt-2018-0031

Source DB:  PubMed          Journal:  Drug Metab Pers Ther        ISSN: 2363-8915


  6 in total

1.  Genetic association of insulin receptor substrate-1 (IRS-1, rs1801278) gene with insulin resistant of type 2 diabetes mellitus in a Pakistani population.

Authors:  Abdullah Abdo Albegali; Muhammad Shahzad; Saqib Mahmood; Muhammad Ikram Ullah
Journal:  Mol Biol Rep       Date:  2019-08-24       Impact factor: 2.316

2.  The combined role of allelic variants of IRS-1 and IRS-2 genes in susceptibility to type2 diabetes in the Punjabi Pakistani subjects.

Authors:  Anam Ijaz; Sana Babar; Sumbal Sarwar; Saleem Ullah Shahid
Journal:  Diabetol Metab Syndr       Date:  2019-08-06       Impact factor: 3.320

3.  BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.

Authors:  Cong Zhang; Chunrui Bo; Lunhua Guo; Pingyang Yu; Susheng Miao; Xin Gu
Journal:  World J Surg Oncol       Date:  2019-12-16       Impact factor: 2.754

4.  Whole-transcriptome analysis of aluminum-exposed rat hippocampus and identification of ceRNA networks to investigate neurotoxicity of Al.

Authors:  Chanting He; Xiaoyan Zhao; Yang Lei; Jisheng Nie; Xiaoting Lu; Jing Song; Linping Wang; Huan Li; Fangqu Liu; Yidan Zhang; Qiao Niu
Journal:  Mol Ther Nucleic Acids       Date:  2021-11-11       Impact factor: 8.886

5.  COBLL1 and IRS1 Gene Polymorphisms and Placental Expression in Women with Gestational Diabetes.

Authors:  Przemyslaw Ustianowski; Damian Malinowski; Michał Czerewaty; Krzysztof Safranow; Maciej Tarnowski; Violetta Dziedziejko; Andrzej Pawlik
Journal:  Biomedicines       Date:  2022-08-09

6.  Endoplasmic reticulum stress may be involved in insulin resistance and lipid metabolism disorders of the white adipose tissues induced by high-fat diet containing industrial trans-fatty acids.

Authors:  Wanqiu Zhu; Xin Niu; Mingxia Wang; Zhao Li; Hong-Kun Jiang; Chuntao Li; Samantha J Caton; Yinglong Bai
Journal:  Diabetes Metab Syndr Obes       Date:  2019-08-29       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.